Health Technology · Pharmaceuticals: Major · NSE: APLLTD · data 2026-10-09
Alembic Pharmaceuticals Limited
Health check: Strong (6.8/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹800.95
Market cap
₹15,733 cr
P/E
22.7
P/B
—
ROE
12.3%
ROCE
11.8%
Debt / equity
0.25
Dividend yield
1.50%
1-year return
-13.9%
52-week high
₹998
52-week low
₹635.8
Operating margin
10.6%
Growth
| Revenue (last 12 months) | ₹7,784 cr |
| Net profit (last 12 months) | ₹693 cr |
| Sales growth, 3 years (yearly) | 9.0% |
| Profit growth, 3 years (yearly) | 25.4% |
Similar companies
Cohance Lifesciences Ltd (COHANCE) · Alivus Life Sciences Ltd (ALIVUS) · Eris Lifesciences Ltd (ERIS) · NATCO Pharma Limited (NATCOPHARM) · Jubilant Pharmova Limited (JUBLPHARMA)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open APLLTD in NSE Scanner →